•  
  •  
  •  
  •  

2025-12-23 11:04:39

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE119A01028

Stock Report

  • Balrampur Chini Mills Ltd Champions Sustainability at Ayodhya's Ram Mandir
  • 'Bioyug on Wheels' rolls into Kochi to spotlight PLA Innovation at KPLEX Expo 2025
  • BCML collaborates with CIPET Ahmedabad to bring 'Bioyug on Wheels'
  • UP CM Shri Yogi Adityanath ji Lays Foundation for India's First PLA Biopolymer Plant by Balrampur Chini Mills Limited
  • Balrampur Chini Mills Limited applauds India's First Comprehensive Bioplastic Policy
  • Balrampur Chini Mills Ltd is set to venture into Poly Lactic Acid manufacturing with a new fully integrated facility
  • Avantika Saraogi appointed as Executive Director of Balrampur Chini Mills Limited
  • Balrampur Chini Mills Ltd allots NCDs of Rs. 140 crore to HDFC Bank
  • Balrampur Chini Mills Ltd declares interim dividend of Rs. 2.50
  • Balrampur Chini Mills Ltd wins 7th ICSI CSR Excellence Award
  • Balrampur Chini Mills Ltd commences commercial production of 170 KLPD capacity
  • Balrampur Chini Mills Ltd commissions commercial production at Maizapur Unit
  • Sumit Mazumder resigns as Chairman of Balrampur Chini Mills Ltd
  • Balrampur Chini Mills Ltd declares interim dividend of Rs. 2.50
  • Balrampur Chini Mills Limited commences additional capacity of 40KLPD
  • CRISIL upgrades long-term rating of Balrampur Chini Mills Ltd

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024